Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ray-Coquard

Showing results (81-90 of 548) with videos related to

Pageof 55
Sort By:
Current Oncology Reports|November 9, 2021
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab TherapyAlexandra Lainé, Travis T Sims, Olivia Le Saux, et al.
Critical Reviews in Oncology/Hematology|August 7, 2024
Impact of molecular testing on the surgical management of advanced epithelial ovarian cancerPierre-Emmanuel Colombo, Christophe Taoum, Michel Fabbro, et al.
Critical Reviews in Oncology/Hematology|September 28, 2013
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancerPierre-Emmanuel Colombo, Michel Fabbro, Charles Theillet, et al.
The Oncologist|September 19, 2020
Pregnancy in Women with Metastatic SarcomasAlexandre Yazigi, Estelle Lecointe-Artzner, Axel Le Cesne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2025
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy managementJean-Sebastien Frenel, Tom Roynard, Cecile Loaec, et al.
Bulletin Du Cancer|July 15, 2003
[Anemia and chemotherapy]Isabelle Ray-Coquard, Thomas Bachelot, Catherine Sebban, et al.
Bulletin Du Cancer|November 30, 2011
[Anticancer drugs management in renal insufficiency patients]Sarah Zimmer-Rapuch, Stéphanie Lheureux, Fabien Brocard, et al.
Bulletin Du Cancer|December 3, 2011
[Antihormonal therapy in breast cancer and mTOR inhibitors]Pierre-Étienne Heudel, Olivier Tredan, Isabelle Ray-Coquard, et al.
Cancers|November 27, 2021
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, et al.
Cancer|February 4, 2009
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Pageof 55

Showing results (81-90 of 548) with videos related to

Sort By:
Pageof 55
Current Oncology Reports|November 9, 2021
Treatment Perspectives for Ovarian Cancer in Europe and the United States: Initial Therapy and Platinum-Sensitive Recurrence after PARP Inhibitors or Bevacizumab TherapyAlexandra Lainé, Travis T Sims, Olivia Le Saux, et al.
Critical Reviews in Oncology/Hematology|August 7, 2024
Impact of molecular testing on the surgical management of advanced epithelial ovarian cancerPierre-Emmanuel Colombo, Christophe Taoum, Michel Fabbro, et al.
Critical Reviews in Oncology/Hematology|September 28, 2013
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancerPierre-Emmanuel Colombo, Michel Fabbro, Charles Theillet, et al.
The Oncologist|September 19, 2020
Pregnancy in Women with Metastatic SarcomasAlexandre Yazigi, Estelle Lecointe-Artzner, Axel Le Cesne, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2025
Pocket guide based on the TNM and FIGO staging systems for classifying patients with locally advanced cervical cancer: a practical tool from the GINECO group for quick and easy managementJean-Sebastien Frenel, Tom Roynard, Cecile Loaec, et al.
Bulletin Du Cancer|July 15, 2003
[Anemia and chemotherapy]Isabelle Ray-Coquard, Thomas Bachelot, Catherine Sebban, et al.
Bulletin Du Cancer|November 30, 2011
[Anticancer drugs management in renal insufficiency patients]Sarah Zimmer-Rapuch, Stéphanie Lheureux, Fabien Brocard, et al.
Bulletin Du Cancer|December 3, 2011
[Antihormonal therapy in breast cancer and mTOR inhibitors]Pierre-Étienne Heudel, Olivier Tredan, Isabelle Ray-Coquard, et al.
Cancers|November 27, 2021
Maintenance Treatment of Newly Diagnosed Advanced Ovarian Cancer: Time for a Paradigm Shift?Paul DiSilvestro, Nicoletta Colombo, Philipp Harter, et al.
Cancer|February 4, 2009
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)Andreas du Bois, Alexander Reuss, Eric Pujade-Lauraine, et al.
Pageof 55